Innospec Inc (NASDAQ: IOSP) has reported earnings for its third fiscal quarter (ending September 30) of $1.58 versus $1.56 for the same period a year ago — an increase of 1%. This result exceeded the […]
For its third fiscal quarter (ending September 30), Viatris Inc (NASDAQ: VTRS) has reported a -3% decline in E.P.S. from $0.29 a year ago to $0.28 in the current quarter. This performance was $-0.46 short […]
Xencor Inc (NASDAQ: XNCR) has reported E.P.S. of $-0.40 for its third fiscal quarter (ending September 30) versus $-0.55 for the same period a year ago. This performance was $0.31 better than the consensus estimate […]
Mercury Systems Inc (NASDAQ: MRCY) has reported a loss for its first fiscal quarter (ending September 30) of $-0.64 versus a loss $-0.26 for the same period a year ago. This result fell short of […]
For its third fiscal quarter (ending September 30), National Research Corp (NASDAQ: NRC) has reported a -6% decline in E.P.S. from $0.34 a year ago to $0.32 in the current quarter. E.P.S. were $1.17 for […]
Premier Inc (NASDAQ: PINC) has reported E.P.S. of $0.38 for its first fiscal quarter (ending September 30) versus $0.36 for the same period a year ago — an increase of 6%. However, this performance was […]
Halozyme Therapeutics Inc (NASDAQ: HALO) stock enjoyed a major increase of 10.0% on 11/7/23. The shares closed at $38.80. The stock has performed in line with the market over the last nine months and has […]
The Hain Celestial Group Inc (NASDAQ: HAIN) has reported a loss for its first fiscal quarter (ending September 30) of $-0.12 versus $0.08 for the same period a year ago — a decline of -250%. […]
Extremely significant positive changes in Fidelity D & D Bancorp Inc (NASDAQ: FDBC) investment behavior have recently occurred: positive upside/downside volume developed, its longer term price trend turned up, and its shorter term price trend […]
On 11/7/23, Via Renewables Inc (NASDAQ: VIA) stock enjoyed a major increase of 13.6%, closing at $7.44. Relative to the market the stock has been extremely weak over the last nine months but has risen […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research